NSAID-Induced Enteropathy in Rheumatoid Arthritis Patients with Chronic Occult Gastrointestinal Bleeding: A Prospective Capsule Endoscopy Study

Gastroenterology Research and Practice - Tập 2013 - Trang 1-10 - 2013
Ilja Tachecí1, P Bradna1, Tomáš Douda1, Drahomíra Baštecká1, Marcela Kopáčová1, Stanislav Rejchrt1, J Bureş1
1Second Department of Internal Medicine-Gastroenterology, Charles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital, Sokolská 581, 500 05 Hradec Králové, Czech Republic

Tóm tắt

Background. The purpose of study was to evaluate the diagnostic yield of capsule endoscopy for NSAID-induced enteropathy and clinical, laboratory, and endoscopic characteristics of disease in patients with rheumatoid arthritis.Methods. 37 rheumatoid arthritis patients (30 women; mean age 55) treated with NSAIDs (>1 month), presented with anaemia and/or positive faecal occult blood testing, entered the study and underwent capsule endoscopy (EndoCapsule; Olympus), laboratory tests, and filled in questionnaires.Results. The prevalence of NSAID-induced enteropathy diagnosed by capsule endoscopy was 68% (25/37), classified as mild (red spots or erosions) in 18 (49%), moderate (10–20 erosions) in 4 (11%), and severe enteropathy (>20 erosions or ulcers) in 3 (8%) patients. We did not find statistically significant relationship between the enteropathy and gender, age, haemoglobin, leukocytes, albumin and CRP, or dyspepsia. The difference between subgroups of NSAIDs according to the COX specificity was not statistically significant.Conclusions. Capsule endoscopy is a highly accurate noninvasive method for evaluation of NSAID-induced enteropathy. It was revealed in a substantial section of the patients with rheumatoid arthritis and occult gastrointestinal bleeding, mostly classified as mild damage. No simple clinical or laboratory markers of the presence or severity of NSAID-induced enteropathy were recognised. This trial is registered withDRKS00004940.

Từ khóa


Tài liệu tham khảo

1998, Journal of Rheumatology, Supplement, 25, 8

10.1097/MOG.0b013e328331549f

1938, The Lancet, 232, 1222, 10.1016/S0140-6736(00)78970-7

1973, The American Journal of Gastroenterology, 59, 162

2000, Journal of Pharmacy & Pharmaceutical Sciences, 3, 137

10.1163/156856003322699546

2002, Gastroenterology, 122, 1913, 10.1053/gast.2002.33647

10.1097/PAT.0b013e328355ea5d

10.1007/s00535-008-2266-6

2012, Tokai Journal of Experimental and Clinical Medicine, 37, 14

2007, The American Surgeon, 73, 344, 10.1177/000313480707300406

1988, Journal of Clinical Pathology, 41, 516, 10.1136/jcp.41.5.516

1994, The American Journal of Roentgenology, 162, 49, 10.2214/ajr.162.1.8273688

2010, Acta Medica, 53, 3

1992, The New England Journal of Medicine, 327, 749, 10.1056/NEJM199209103271101

1991, The Lancet, 337, 1550

10.1016/S1542-3565(04)00603-2

10.1016/S1542-3565(04)00619-6

10.1016/j.cgh.2007.04.031

10.1016/j.cgh.2007.12.023

10.1016/j.dld.2012.12.005

2007, Česká a Slovenská Gastroenterologie a Hepatologie, 61, 269

10.1055/s-0029-1243968

10.1016/j.gie.2008.02.037

1998, Gut, 43, 506, 10.1136/gut.43.4.506

10.1016/S1072-7515(97)00067-7

1987, The Lancet, 2, 711

10.1111/j.1365-2036.2007.03312.x

10.1080/00365520701794121

10.1053/bega.2001.0231

10.1097/00007611-199804000-00018

10.1097/01.mcg.0000135367.66159.87

1991, Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs

10.1097/MEG.0b013e3282fa7508

1998, The British Journal of Rheumatology, 37, 946, 10.1093/rheumatology/37.9.946

1998, The British Journal of Rheumatology, 37, 937, 10.1093/rheumatology/37.9.937

10.1016/j.cgh.2007.04.031